THERANOSTIC4GLIO Workshop

 

 

1st International Workshop on the Development of Innovative Theranostic Platforms for GLioblastoma Diagnosis and Treatment


Theranostic4GLIO

July 21st 2025 – 10:30am

DEPARTMENT OF CHEMISTRY, UNIVERSITY OF IOANNINA, IOANNINA, GREECE

WORKSHOP PROGRAM

Time 
(EEST, UTC+3)
Session / Speaker / Title
10:30-11:00Arrival
11:00-11:15Welcome Remarks:

  • Dimitra Chela, Professor, President of the Department of Chemistry, University of Ioannina
  • Andreas Tzakos, Professor, Department of Chemistry, University of Ioannina
11:15-11:30“Designing of peptides-based theragnostic molecules for selective targeting of glioblastoma” 

Aaqib Ullah, Ph.D

Department of Chemistry, University of Ioannina,  Ioannina, Greece

11:30-11:45“Multimodal Theranostic Approaches for Glioblastoma Using Fluorescent–DOTA–Radiometal Conjugates”

Murugan Chinnarasu , Chemist, MSc., PhD Candidate 

Department of Chemistry, University of Ioannina,  Ioannina, Greece

11:45-12:00“Establishment of novel LC-MS based methods for quantification of innovative theranostics in human plasma”

Nikolaos Parisis, Chemist, MSc., PhD Candidate

Department of Chemistry, University of Ioannina,  Ioannina, Greece

12:00-12:15“Radiolabeling of A Novel Triazine-Based Molecule with Technetium-99m as A Theranostic Tool for Glioma”

Adamantia P. Apostolopoulou, Chemist MSc., PhD Candidate in Radiopharmaceuticals

Radiochemical Studies Laboratory, National Center for Scientific Research “Demokritos”

12:15-12:30“In vivo Tracking of Cell-Penetrating Peptides After Radiolabeling with Theranostic Radionuclides”

Danae Efremia Bajwa, Radiochemist, PhD candidate

Radiochemical Studies Laboratory, National Center for Scientific Research “Demokritos”

12:30-12:45“Radiolabeling of novel peptide conjugate with positron emitter Ga-68 for glioma diagnosis”

Danai Bouzioti, Radiochemist, MSc.

Radiochemical Studies Laboratory, National Center for Scientific Research “Demokritos”

12:45-13:00“Design, synthesis and evaluation of napthalimide-based platform as theranostic agent for imaging and treatment of glioma”

Vasileios-Panagiotis Bistas, Chemist, MSc

Department of Chemistry, University of Ioannina, Ioannina, Greece

13:00-13:30Coffee break
13:30-13:45“Presentation of the SYN Innovation Laboratories S.A. pharmaceutical company towards the development of radiopharmaceuticals”

Savvas Thalasselis, Managing Director 

SYN Innovation Laboratories S.A.

13:45-14:00“PET Image Reconstructions via Chebyshev Interpolation”

Nicholas E. Protonotarios, George A. Kastis

Institute of Nuclear and Radiological Science and Technology, Energy and Safety (INRASTES), National Center for Scientific Research “Demokritos”, Aghia Paraskevi, Greece

14:00-14:20“Theranostics/Radiotheranostics: Developments and Prospects for the Future of Oncology”

Penelope Bouziotis, Research Director

Radiochemical Studies Laboratory, NCSR Demokritos

14:20-14:40“Glioblastoma diagnosis and therapy: Current surgical challenges”

Georgios Alexiou, Associate Professor

Neurosurgical Institute, University of Ioannina, Ioannina, Greece

14:40-15:00“A Spline-Based Method for Noninvasive Quantification of Glucose Metabolism in Mice: A comparative study”

George A. Kastis, Nicholas E. Protonotarios, Penelope Bouziotis, Alexandros Vrachliotis

Institute of Nuclear and Radiological Science and Technology, Energy and Safety (INRASTES), National Center for Scientific Research “Demokritos”, Aghia Paraskevi, Greece

15:00-15:15“Smart peptides for glioma imaging and therapy”

Evgenia Fotou, Chemist, MSc., PhD

Department of Chemistry, University of Ioannina, Ioannina, Greece

15:15-15:30“Novel Theranostic Tools for Glioblastoma: Photosensitizers Inspired by Tetrofosmin and 5-ALA for Fluorescence-Guided Surgery and Photodynamic Therapy”

Stavroula Kyrkou, Chemist, MSc., PhD Candidate

Department of Chemistry, University of Ioannina, Ioannina, Greece

15:30-15:45“A novel multifunctional theranostic platform for glioblastoma diagnosis and treatment”

Christina Bika, Chemist, MSc., PhD, Candidate

Department of Chemistry, University of Ioannina, Ioannina, Greece

15:45-16:10“Diffuse midline glioma and advances in the treatment strategies”

Roberta Rehder, MD, PhD, Chief of pediatric neurosurgery, Santa marcelina Hospital, São Paulo, Brazil, Neurosurgery Research fellow , Boston children’s hospital, Neurosurgery Research fellow, John’s Hopkins hospital

16:10-16:30

Round table on the Development of Theranostic Molecule for Glioblastoma Diagnosis & Treatment 

Closing Remarks


This project is carried out within the framework of the National Recovery and Resilience Plan Greece 2.0,
funded by the European Union – NextGenerationEU, under the call RESEARCH-CREATE-INNOVATE (Implementation body: MIA RI)
Project code: TAEDK-06189, MIS: 5149205